#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
Treatment options available their doses in IIM
New treatment strategies and approaches to young adults with inflammatory myositis
Treatment options available their doses in IIM
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
♦️MTX+GC>>MTX+CIC>GC alone
New treatment strategies and approaches to young adults with inflammatory myositis
♦️MTX+GC>>MTX+CIC>GC alone
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
🪩RIM trial
♦️Better response in JDM
♦️Antibody positive (Mi2,Jo1 +ve ) performed better than Ab negetive
New treatment strategies and approaches to young adults with inflammatory myositis
🪩RIM trial
♦️Better response in JDM
♦️Antibody positive (Mi2,Jo1 +ve ) performed better than Ab negetive
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
🪩Abatacept in IIM (ARTEMIS)
♦️Trend towards improvement seen
♦️ post shoc shows might be better in ASS and PM
New treatment strategies and approaches to young adults with inflammatory myositis
🪩Abatacept in IIM (ARTEMIS)
♦️Trend towards improvement seen
♦️ post shoc shows might be better in ASS and PM
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
🪩Proderm study and IVIG in IIM
♦️Positive study with good response with IVIG
New treatment strategies and approaches to young adults with inflammatory myositis
🪩Proderm study and IVIG in IIM
♦️Positive study with good response with IVIG
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
🪩 Belimumab also showed trend towards improvement in IIM
New treatment strategies and approaches to young adults with inflammatory myositis
🪩 Belimumab also showed trend towards improvement in IIM
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
🪩JAKi/Tofacitinib show promise in
♦️Refractory Skin disease
♦️Clacinosis
♦️Amyopathic DM with ILD
♦️Early signals for efficacy in myositis too
New treatment strategies and approaches to young adults with inflammatory myositis
🪩JAKi/Tofacitinib show promise in
♦️Refractory Skin disease
♦️Clacinosis
♦️Amyopathic DM with ILD
♦️Early signals for efficacy in myositis too
#EULAR2022
New treatment strategies and approaches to young adults with inflammatory myositis
Summary Slide
New treatment strategies and approaches to young adults with inflammatory myositis
Summary Slide
Loading suggestions...